The objective of this report is to provide updated guidance in developing an appropriate analytical scope of testing for novel psychoactive substances (NPS) in the United States (and around the world) based on current trends and intelligence. This report is based on information available in Q2 2024 and early Q3 2024 and is subject to change along with the drug market.
Loading...
cfsre Trend Reports: NPS – Q3 2024 October 11, 2024
NDEWS: Substance use in the past 12 months: Tampa, FL Survey dates: August 16–17, 2024 October 9, 2024
NDEWS: Sentinel Site Report, July 2024 October 9, 2024
NDEWS Hotspot Alerts September 10-16, 2024 September 20, 2024
Federal Register: Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I September 17, 2024
National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913
Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy
Reload document 
Open in new tab